The Cheapest Moment to Consolidate Is the One Everybody Lets Expire

health systems margin improvement physician groups tactics Oct 26, 2026

What It Costs You Monday — a 10-part series on healthcare margin at the operating level. Start with Part 1: The Opening. Previous: Part 4: The Basics, and the Labor Pool. You're reading Part 5: Declining to Re-Buy.

Strategy four on the list reads: divest non-core services and programs.

Fine as far as it goes. But by the time you are seriously considering divestment, you are usually past the question that would have helped — because before you get there, you are probably not trying to get smaller at all. You are trying to optimize the programs you already have.

"You are not writing anything off. You are simply declining to re-buy."

THE RULE ISN'T "CORE"

The rule is not that an asset has to be core. It is that it has to be financially disciplined and delivering a value you have named.

Those are two separate tests, and a lot of organizations apply neither. "Core" is an identity question. The other two are operating questions, and they are the ones that decide whether the asset is earning its place.

WHAT IT LOOKS LIKE WHEN IT ISN'T

Take home health.

Health systems own home health agencies that sit outside the hospital. The EMRs do not quite talk to each other. The leadership team is different. Sometimes the leadership is outsourced to a management company. And you end up with an agency that drifts — it never develops the intensity of a home health agency owned by a home health operator, because nobody inside your organization wakes up thinking about it.

Home health is an add-on service for a health system. If you are going to have it, it has to produce value for you specifically. Maybe not standalone home health margin, but something. Most likely lowering your inpatient cost through length-of-stay improvement.

Name that. Then measure it.

Because if you take your eye off it, you are eating an asset that costs more and more while delivering less and less.

THE DECISION POINT NOBODY SCHEDULES

And when the asset starts to deteriorate, that is the decision point.

Before you renew it, look hard at whether the volume can be absorbed into something you already own. If the MRI is about to go, can that volume move somewhere else?

Consolidating capital at replacement time lowers your overall fixed cost, and it is the cheapest moment you will ever get to do it — because you are not writing anything off. You are simply declining to re-buy.

Most organizations treat replacement as automatic and let that option expire every cycle. The capital request comes up, it gets approved because the machine is old, and a decision that could have permanently taken fixed cost out of the business gets made as a procurement formality.

Nobody is being careless. The replacement cycle just does not arrive labelled as a strategic decision, so it does not get treated as one.

THE SAME LOGIC APPLIES TO EVERYTHING YOU PUSHED OUT

Imaging centers, physical therapy, satellite sites. A lot of money has gone into spreading services around the community, and spreading services spreads cost and raises cost per unit.

An MRI running at 30% capacity might be profitable on its own P&L and still be destroying margin, because you are paying for a whole other tech to run it. The site-level P&L cannot see that. Only the system view can — which is exactly why the site-level P&L is the number that usually gets presented.

Consolidating down may mean patients drive a little further. That is the cost of keeping your margins in place, and a hospital that survives is worth more to a community than a convenient one that closes.

FIVE QUESTIONS WORTH ANSWERING IN WRITING

For each non-core service we own: what value does it produce for us specifically, in one sentence — and who measures that?
Which of our assets is fine on paper and actively managed by nobody?
What capital comes up for replacement in the next twenty-four months?
For each of those: could the volume be absorbed by something we already own?
Are we evaluating site-level P&Ls or system-level cost per unit — and which one gets presented to the board?

Divestment is the loud decision. Declining to re-buy is the quiet one, and it is usually worth more.

Ready to talk about where your organization stands? Book a free strategy session · Connect with me on LinkedIn, where this series runs.

DR Advisors — Physician's Trusted Advisor